The Heterogeneous Nuclear Ribonucleoprotein K (hnRNP K) Interacts with Dengue Virus Core Protein
- Amplification of the Sylvatic Cycle of Dengue Virus Type 2, Senegal, 1999-2000: Entomologic Findings and Epidemiologic Considerations. Diallo, Mawlouth; Ba, Yamar; Sall, Amadou A.; Diop, Ousmane M.; Ndione, Jacques A.; Mondo, Mireile; Girault, Lang; Mathiot, Christian // Emerging Infectious Diseases;Mar2003, Vol. 9 Issue 3, p362
Presents a study which focused on the amplification of the sylvatic cycles of dengue virus type 2 in Senegal from 1999-2000. Materials and methods; Results; Discussion.
- Dengue type 3 infection--Nicaragua and Panama, October-November 1994. Palacio, M.; Amador, J.J. // MMWR: Morbidity & Mortality Weekly Report;1/20/1995, Vol. 44 Issue 2, p21
Focuses on the influence of dengue virus activity in the Americas between 1980 to 1994. Role of serotypes 1, 2 and 4 ( DEN-1, DEN-2, and DEN-4); Announcement by Ministry of Health of Nicaragua of isolation of DEN-3; Plans for control of the virus; Editorial notes on the dengue fever.
- Dengue and dengue hemorrhagic fever (DHF). // Emerging Infectious Diseases;Jan-Mar98, Vol. 4 Issue 1, p136
Looks at the number of cases of dengue which are reported annually. Factors which contribute to the emergence of dengue; What correct diagnosis of dengue infection requires; Length of time the dengue hemorrhagic (DHF) takes before the sudden onset of fever and nonspecific signs and symptoms;...
- ERRATUM. // Journal of Infectious Diseases;11/15/2005, Vol. 192 Issue 10, p1863
Presents a correction to an article on dengue virus published in the August 1, 2005 issue of "The Journal of Infectious Diseases."
- Measuring Dengue Enhancing Antibodies: Caveats. Haistead, Scott B. // Journal of Infectious Diseases;2/15/2006, Vol. 193 Issue 4, p601
A letter to the editor is presented in response to the paper "Dengue virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection," by K. Laoprasopwattana, D.H. Libraty, and T.P. Endy in the February 2005 issue.
- Antibody-Dependent Enhancement in Dengue Virus Infections. Burke, Donald S.; Kliks, Srisakul // Journal of Infectious Diseases;2/15/2006, Vol. 193 Issue 4, p601
A letter to the editor is presented in response to the paper "Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever," by S.C. Kliks, A. Nisalak, W.E. Brandt, L. Wall, and D.S. Burke in a 1989 issue.
- Dengue-Specific T Cell Responses in Peripheral Blood Mononuclear Cells Obtained prior to Secondary Dengue Virus Infections in Thai Schoolchildren. Mangada, Marlou M.; Endy, Timothy P.; Nisalak, Ananda; Chunsuttiwat, Supamit; Vaughn, David W.; Libraty, Daniel H.; Green, Sharone; Ennis, Francis A.; Rothman, Alan L. // Journal of Infectious Diseases;6/15/2002, Vol. 185 Issue 12, p1697
Children who experience secondary dengue virus (DV) infections are at increased risk for dengue hemorrhagic fever. To study the effect of preexisting T cell responses to DV on the severity of secondary virus infection, peripheral blood mononuclear cells (PBMC) from 10 subsequently hospitalized...
- Facilitation of Cell Adhesion by Immobilized Dengue Viral Nonstructural Protein 1 (NS1): Arginine-Glycine-Aspartic Acid Structural Mimicry within the Dengue Viral NS1 Antigen. Hsin-Hou Chang; Huey-Fen Shyu; Yo-Ming Wang; Der-Shan Sun; Rong-Hwa Shyu; Shiao-Shek Tang; Yao-Shine Huang // Journal of Infectious Diseases;9/15/2002, Vol. 186 Issue 6, p743
Dengue virus infection causes life-threatening hemorrhagic fever. Increasing evidence implies that dengue viral nonstructural protein 1 (NS1) exhibits a tendency to elicit potentially hazardous autoantibodies, which show a wide spectrum of specificity against extracellular matrix and platelet...
- Editorial. Hannongbua, Supa // Current Computer-Aided Drug Design;Jun2007, Vol. 3 Issue 2, p85
The article discusses various reports published within the issue, including one on the protein of the dengue virus, one on HIV-1 reverse transcriptase (HIV-1 RT), and one on emerging diseases such as avian influenza.